International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Mol Med Rep 23: [Related article:] 343, 2021; DOI: 10.3892/mmr.2021.11982
Following the publication of the above article, the authors have realized that the Funding section of the Declarations on p. 7 was written incorrectly: The text here should have appeared as follows: ‘This work was supported by the Research Fund Subsidy Project of Hunan Provincial Committee on Health Commission (grant no. 20200179) and Xiang Wei Medical Administration Medical Office Memorandum (2019) No. 118 and the Research Fund of Hunan Provincial Department of Education (grant no. 20C1163)’.
The authors regret their oversight in providing this incorrect information in the Funding section of their paper. They thank the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this corrigendum, and apologize to the readership of the Journal and to the inappropriately credited funding bodies in question for any inconvenience caused.